The video presents a bearish outlook for Bristol-Myers Squibb (BMY). On October 2nd, 2025, the system ranked it as a sell candidate, with a score of -3.82. The stock is in a declining trend in the short term, with a potential decrease of 3.7% over the next three months. The trading levels indicate the weekly volatility is 3.51%, and a first support at $45.10 is expected. If it’s broken, further declines are anticipated. Elkins David V had a sell of 56,000 shares of common stock with par value of $0.10, Short Bartie Wendy buy of 1,235 shares, Short Bartie Wendy sell of 632 shares, Short Bartie Wendy sell of 1,235 shares and Massacesi Cristian buy of 204,691 shares. The stock expected to open up $0.540 and start trading at $46.27.